Ganoderma lucidum: A potent pharmacological macrofungus

Current Pharmaceutical Biotechnology

Volumn 10, Issue 8, 2009, Pages 717-742

  Sanodiya, Bhagwan S ^a   Thakur, Gulab S ^a   Baghel, Rakesh K ^a   Prasad, G B K S ^b   Bisen, P S ^a,b  

^a Bisen Biotech and Biopharma Pvt Ltd   (India)

^b JIWAJI UNIVERSITY   (India)

Author keywords

Anti HIV; Anti tumor; Ganoderic acid; Ganoderma lucidum; Immune modulation; Polysaccharides; Submerged fermentation

Indexed keywords

3 OXO 5ALPHA LANOSTA 8,24 DIEN 21 OIC ACID; ACICLOVIR; ACID PROTEIN; ACID PROTEIN BOUND POLYSACCHARIDE; ALANINE; ANTIHYPERTENSIVE AGENT; ASPARTIC ACID; COPPER ION; FATTY ACID; GANODERIC ACID; GANODERMA LUCIDUM EXTRACT; GLUTAMIC ACID; GLYCINE; HEAVY METAL; KRESTIN; METHIONINE; MYCELIUM EXTRACT; NUCLEOTIDE; POLYSACCHARIDE; PROLINE; PROTEIN; SERINE; STEROID; STEROL; THREONINE; TRITERPENOID; TSUGARIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALINE; VIDARABINE;

ANTIALLERGIC ACTIVITY; ANTIANDROGENIC ACTIVITY; ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIDIABETIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BATCH FERMENTATION; BIOMASS; BIOSORPTION; BRONCHITIS; CARDIOVASCULAR FUNCTION; CHEMOPROPHYLAXIS; CHOLESTEROL METABOLISM; CHRONIC HEPATITIS; CLINICAL TRIAL; COMPLEMENT SYSTEM; DECOMPOSER; DIABETES MELLITUS; DRUG ACTIVITY; DRUG BINDING; DRUG EFFICACY; DRUG ISOLATION; DRUG MEGADOSE; DRUG STRUCTURE; EFFECTOR CELL; ESTROGEN ACTIVITY; FED BATCH FERMENTATION; FUNGUS; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERGLYCEMIA; HYPERTENSION; IMMOBILIZED CELL CULTURE; IMMUNE RESPONSE; IMMUNOMODULATION; INSOMNIA; LIPID METABOLISM; LIVER PROTECTION; MACROFUNGUS; MACROPHAGE; MALIGNANT NEOPLASTIC DISEASE; MAST CELL; MITOGENESIS; MUTAGENIC ACTIVITY; MYCELIUM; NATURAL KILLER CELL; NEURASTHENIA; NONHUMAN; NUTRIENT CONTENT; PH; RADIATION PROTECTION; REVIEW; SOLID STATE FERMENTATION; SPECIES COEXISTENCE; STOMACH ULCER; T LYMPHOCYTE; TAXONOMIC RANK; TREATMENT INDICATION; ULCEROGENESIS; WOOD;

ANIMALS; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; REISHI;

BASIDIOMYCOTA; GANODERMA LUCIDUM;

EID: 73649107884     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920109789978757     Document Type: Review

References (154)

1. Wasson, R.G. (1968) Soma: Divine Mushroom of Immortality, Harcourt Brace Jovanovich Inc.; Los Angeles, USA, pp. 80-92.
2. Yun, T.K. (1999) Asian studies on cancer chemoprevention. Ann. N. Y. Acad. Sci., 889, 157-192.
3. Shiao, M.S.; Lee, K.R.; Lin, L.J. and Wang, C.T. (1994) Natural products and biological activities of the Chinese medical fungus, Ganoderma lucidum, in: Food Phytochemicals for Cancer Prevention. II: Teas, Spices and Herbs, (Ho, C.T., Osawa, T., Huang, M.T. and Rosen, R.T.; Eds.), American Chemical Society: Washington, DC, p. 342-354.
4. Wasser, S.P. and Weis, A.L. (1997) Medicinal Mushrooms: Ganoderma lucidum, (Curtis: Fr.) P. Karst., (Nevo, E., Ed.), Peledfus Publ. House: Haifa, Israel, p. 39.
5. Chang, S.T. and Buswell, J.A. (1999) Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae) - A medicinal mushroom. Int. J. Med. Mushrooms, 1, 139-146.
6. Jong, S.C. and Birmingham, J.M. (1992) Medicinal benefits of the mushroom Ganoderma. Adv. Appl. Microbiol., 37, 101-134.
7. nd ed., Botanica Press, Inc.; Santa Cruz, USA, p. 252.
8. nd ed., The Haworth Herbal Press: New York, Oxford, pp. 825-855.
9. Gao, Y.; Lan, J.; Dai, X.; Ye, J. and Zhou, S.H. (2004) A phase I/II study of Ling Zhi mushroom Ganoderma lucidum. (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) extract in patients with type II diabetes mellitus. Int. J. Med. Mushrooms, 6 (1), 33-39.
10. Gao, Y.; Zhou, S.H.; Huang, M. and Xu, A. (2003) Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae): a review. Int. J. Med. Mushrooms, 5 (3), 235-246.
11. Gao, Y.; Zhou, S.; Chen, G.; Dai, X.; Ye, J. and Gao, H. (2002) A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, Reishi mushroom) extract in patients with chronic hepatitis B. Int. J. Med. Mushrooms, 4, 321-327.
12. Gao, Y.; Shufeng, Z.; Jianbo, W.; Min, H. and Anlong, X. (2002) Mechanism of the antiulcerogenic effect of Ganoderma lucidum polysaccharides on indomethacin-induced lesions in the rat. Life Sci., 72, 731-745.
13. Gao, Y.; Zhou, S.H.; Chen, G.; Dai, X. and Ye, J. (2002) A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. extract (ganopoly) in patients with advanced cancer. Int. J. Med. Mushrooms, 4(3), 207-214.
14. Wasser, S.P. and Weis, A.L. (1999) Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: A modern perspective. Crit. Rev. Immunol., 19, 65-96.
15. Wasser, S.P. (2002) Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl. Microbiol. Biotechnol., 60, 258-274.
16. Smith, J.; Rowan, N. and Sullivan, R. (2002) Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatment; Special Report Commissioned by Cancer Research UK, The University of Strathclyde in Glasgow, p. 256.
17. Mizuno, T. (1995) Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects. Food Rev. Int., 11(1), 151-166.
18. Liu, G.T. (1999) Recent advances in research of pharmacology and clinical applications of Ganoderma P. Karst. species (Aphyllophoromycetideae) in China. Int. J. Med. Mushrooms, 1(1), 63-68.
19. Wasser, S.P. and Weis, A.L. (1999) Medicinal properties of substances occurring in higher Basidiomycetes mushrooms: current perspectives (review). Int. J. Med. Mushrooms, 1(1), 31-62.
20. Zhou, S.H. and Gao, Y. (2002) The immunomodulating effects of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Ling Zhi, reishi mushroom) (Aphyllophoromycetideae). Int. J. Med. Mushrooms, 4(1), 1-11.
21. Vickers, A. (2000) Recent advances: Complementary medicine. Br. Med. J., 321, 683-686.
22. Zhou, S.H.; Kestell, P.; Baguley, B.C. and Paxton, J.W. (2002) 5,6-Dimethylxanthenone-4-acetic acid: a novel biological response modifier for cancer therapy. Invest. New Drugs, 20, 281-295.
23. Kartikeyan, S.; Bharmal, R.N.; Tiwari, R.P. and Bisen, P.S. (2007) HIV and AIDS: Basic Elements and Priorities, Springer Verlag: Dordrecht, The Netherlands.
24. Matsushita, S. and Kimura, T. (2002) Advance in treatment strategy and immune reconstruction against HIV1 infection. Microbiol. Immunol., 46, 231-239.
25. Menendez-Arias, L. (2002) Targeting HIV: antiretroviral therapy and development of drug resistance. Trends Pharmacol. Sci., 23, 381-388.
26. Vermani, K. and Garg, S. (2002) Herbal medicines for sexually transmitted diseases and AIDS. J. Ethnopharmacol., 80, 49-66.
27. Sahar, E.M.; Meselhy, R.M.; Norio, N.; Yasuhiro, T.; Masao, H.; Nobuko, K.; Kunitada, S.; Takuya, K. and Toru, O. (1997) Anti-HIV-1 and Anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry, 49(6), 1651-1657.
28. Smith, D.C.; Redman, B.G.; Flaherty, L.E.; Li, L.; Strawderman, M. and Pienta, K.J. (1998) A phase II trial of oral diethylstilbesterol as a second line hormonal agent in advanced prostate cancer. Urology, 52, 257-260.
29. Min, B.S.; Nakamura, N.; Miyashiro, H.; Bae, K.W. and Hattori, M. (1999) Triterpens from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1- protease. Chem. Pharm. Bull., 46, 1607-1612.
30. Kim, H.W.; Shim, M.J.; Choi, E.C. and Kim, B.K. (1997) Inhibition of cytopathic effect of human immunodeficiency virus-1 by water-soluble extract of Ganoderma lucidum. Arch. Pharm. Res., 20, 425-431.
31. Kino, K.; Yamashita, A.; Yamaoka, K.; Watanabe, J.; Tanaka, S.; Ko, K.; Shimizu, K. and Tsunoo, H. (1989) Isolation and characterization of a new immunomodulatory protein, ling zhi-8 (LZ-8), from Ganoderma lucidium. J. Biol. Chem., 264, 472-478.
32. Haak-Frendscho, M.; Kino, K.; Sone, T. and Jardieu, P. (1993) Ling Zhi-8: a novel T cell mitogen induces cytokine production and up regulation of ICAM-1 expression. Cell. Immunol., 150, 101-113.
33. Van der Hem, L.G.; Van der Vliet, J.A.; Bocken, C.F.; Kino, K.; Hoitsma, A.J. and Tax, W.J. (1995) Ling Zhi-8: studies of a new immunomodulating agent. Transplantation, 60, 438-443.
34. Mao, T.; Van De Water, J.; Keen, C.L.; Stern, J.S.; Hackman, R. and Gershwin, M.E. (1999) Two mushrooms, Grifola frondosa and Ganoderma lucidum, can stimulate cytokine gene expression and proliferation in human T lymphocytes. Int. J. Immunother., 15, 13-22.
35. Lin, W.H.; Hung, C.H.; Hsu, C.I. and Lin, J.Y. (1997) Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by a yeast two-hybrid system and site-directed mutagenesis. J. Biol. Chem., 272, 20044-20048.
36. Zhang, L.X.; Mong, H. and Zhou, X.B. (1993) Effect of Japanese Ganoderma lucidum on production of interleukin-2 from murine splenocytes. Chung-Kuo Chung Hsiii Chieh Ho Tsa Chih, 13, 613-615.
37. Lei, L.S. and Lin, Z.B. (1992) Effect of Ganoderma polysaccharides on T cell sub populations and production of interleukin 2 in mixed lymphocyte response. Acta Pharmaceutica Sinica, 27, 331-335.
38. Wang, S.Y.; Hsu, M.L.; Hsu, H.C.; Tzeng, C.H.; Lee, S.S.; Shiao, M.S. and Ho, C.K. (1997) The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer, 70, 699-705.
39. Won, S.J.; Lee, S.S.; Ke, Y.H. and Lin, M.T. (1989) Enhancement of splenic NK cytotoxic activity by the extracts of Ganoderma lucidum mycelium in mice. J. Biomed. Lab. Sci., 2, 201-213.
40. Lee, S.S.; Wei, Y.H.; Chen, C.F.; Wang, S.Y. and Chen, K.Y. (1995) Antitumor effects of Ganoderma lucidum. J. Chin. Med., 6, 1-12.
41. Won, S.J.; Lin, M.T. and Wu, W.L. (1992) Ganoderma tsugae mycelium enhances splenic natural killer cell activity and serum interferon production in mice. Jpn. J. Pharmacol., 59, 171-176.
42. Han, M.D.; Lee, E.S.; Kim, Y.K.; Lee, J.W.; Jeong, H. and Yoon, K.H. (1998) Production of nitric oxide in raw 264.7 macrophages treated with ganoderan, the beta-glucan of Ganoderma lucidum. Korean J. Mycol., 26, 246-255.
43. Li, M.C.; Lei, L.S.; Liang, D.S.; X, Z.M.; Yuan, J.H.; Yang, S.Q. and Sun, L.S. (2000) Effect of Ganoderma lucidum polysaccharides on oxygen free radicals in murine peritoneal macrophages. Chin. J. Pharamacol. Toxicol., 14, 65-68.
44. Oh, J.Y.; Cho, K.J.; Chung, S.H.; Kim, J.H.; Lillehoj, H.S. and Chung, K.S. (1998) Activation of macrophages by GLB, a protein-polysaccharide of the growing tips of Ganoderma lucidum. Yakhak Hoeji (Korean), 42, 302-306.
45. Nogami, M.; Ito, M.; Kubo, M.; Takahashi, M.; Kimura, H. and Matsuike, Y. (1986) Studies on Ganoderma lucidum. VII. Anti-allergic effect. J. Pharmaceut. Soc. Jpn., 106, 600-604.
46. Nogami, M.; Tsuji, Y.; Kubo, M.; Takahashi, M.; Kimura, H. and Matsuike, Y. (1986) Studies on Ganoderma lucidum. VI. Antiallergic effect. J. Pharmaceut. Soc. Jpn., 106, 594-599.
47. Kohda, H.; Tokumoto, W.; Sakamoto, K.; Fujii, M.; Hirai, Y.; Yamasaki, K.; Komoda, Y.; Nakamura, H.; Ishihara, S. and Uchida, M. (1985) The biologically active constituents of Ganoderma lucidum (Fr.) Karst. Histamine release-inhibitory triterpenes. Chem. Pharm. Bull., 33, 1367-1374.
48. Tasaka, K.; Akagi, M.; Miyoshi, K.; Mio, M. and Makino, T. (1988) Anti-allergic constituents in the culture medium of Ganoderma lucidum. (I). Inhibitory effect of oleic acid on histamine release. Agents Actions, 23, 153-156.
49. Tasaka, K.; Mio, M.; Izushi, K.; Akagi, M. and Makino, T. (1988) Anti-allergic constituents in the culture medium of Ganoderma lucidum. (II). The inhibitory effect of cyclooctasulfur on histamine release. Agents Actions, 23, 157-160.
50. Kino, K.; Sone, T.; Watanabe, J.; Yamashita, A.; Tsuboi, H.; Miyajima, H. and Tsunoo, H. (1991) Immunomodulator, LZ-8, prevents antibody production in mice. Int. J. Immunopharmacol., 13, 1109-1115.
51. Lee, J.W.; Chung, C.H.; Jeong, H. and Lee, K.H. (1990) Effects of alkali extract of Ganoderma lucidum IY007 on complement andres. Korean J. Mycol., 18, 137-144.
52. Yang, Q.Y. and Pai, S.S. (2000) The anti-ageing effects of Ganoderma essence. Proc. Int. Meet. Ganoderma Sci., Beijing, p. 30.
53. Miyazaki, T. and Nishijima, M. (1981) Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem. Pharm. Bull., 29, 3611-3616.
54. Usui, T.; Iwasaki, Y.; Hayashi, K.; Mizuno, T.; Tanaki, M.; Shinkai, K. and Arakawa, M. (1981) Antitumor activity of water-soluble beta-D-glucan elaborated by Ganoderma applanatum. Agric. Biol. Chem., 45, 323-326.
55. Usui, T.; Iwasaki, Y.; Mizuno, T.; Tanaki, M.; Shinkai, K. and Arakawa, M. (1983) Isolation and characterization of antitumor active beta-D-glucans from the fruit bodies of Ganoderma applanatum. Carbohydr. Res., 115, 273-280.
56. Sone, Y.; Okuda, R.; Wada, N.; Kishida, E. and Misaki, A. (1985) Structural and anti-tumor activities of polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric. Biol. Chem., 49, 2641-2653.
57. Kishida, E.; Okuda, R.; Sone, Y. and Misaki, A. (1988) Fractionation structures and antitumor activities of the polysaccharides of Reishi, the fruiting body of Ganoderma lucidum. Osaka-Shiritsu Daigaku Seikatsukagakubu Kiyo, 35, 1-10.
58. Zhang, J.; Wang, G.; Li, H.; Zhuang, C.; Mizuno, T.; Ito, H.; Mayuzumi, H.; Okamoto, H. and Li, J. (1994) Antitumor active protein-containing glycans from the Chinese mushroom songshan lingzhi, Ganoderma tsugae mycelium. Biosci. Biotechnol. Biochem., 58, 1202-1205.
59. Cheong, J.; Jung, W. and Park, W. (1999) Characterization of an alkali-extracted peptidoglycan from Korean Ganoderma lucidum. Arch. Pharm. Res., 22, 515-519.
60. Toth, J.O.; Luu, B. and Ourisson, G. (1983) Ganoderic acid T and Z: cytotoxic triterpenes from Ganoderma lucidum (Polyporaceae). Tetrahedon Lett., 24, 1081-1084.
61. Toth, J.O.; Luu, B.; Beck, J.P. and Ourisson, G. (1983) Chemistry and biochemistry of oriental drugs. Part IX. Cytotoxic triterpenes from Ganoderma lucidum (Polyporaceae): structures of ganoderic acids U-Z. J. Chem. Res. Synop., 12, 299.
62. Lin, C.N.; Tome, W.P. and Won, S.J. (1991) Novel cytotoxic principles of Formosan Ganoderma lucidum. J. Nat. Prod., 54, 998-1002.
63. Konopski, Z.; Smedsrod, B.; Seljelid, R. and Eskeland, T. (1994) A novel immunomodulator soluble aminated β-1,3-D-glucan: binding characteristics to mouse peritoneal macrophages. Biochem. Biophys. Acta, 1221, 61-65.
64. Mueller, A.; Raptis, J.; Rice, P.J.; Kalbfleisch, J.H.; Stout, R.D.; Ensley, H.E.; Browder, W. and Williams, D.L. (2000) The influence of glucan polymer structure and solution conformation on binding to (1→3)-beta-D- glucan receptors in a human monocyte-like cell line. Glycobiology, 10, 339-346.
65. Battle, J.; Ha, T.Z.; Li, C.F.; Dellabeffa, V.; Rice, P.; Kalbfleisch, J.; Browder, W. and Williams, D. (1998) Ligand binding to the (1→3)-beta-D-glucan recpetor stimulates NF-kappa B activation, but not apoptosis in U937 cells. Biochem. Biophys. Res. Commun., 249, 499-504.
66. Muller, A.; Rice, P.J.; Ensley, H.; Coogan, P.S.; Kalbfleisch, J.H.; Kelley, J.L.; Love, E.J.; Portera, C.A.; Ha, T.Z.; Browder, I.W. and Williams, D.L. (1996) Receptor binding and internalization of a water-soluble (1→3)-beta-D-glucan biologic response modifier in two monocyte macrophage cell lines. J. Immunol., 156, 3418-3425.
67. Zhong, L.; Jiang, D.Z. and Wang, Q.R. (1999) Effects of Ganoderma lucidum (Leyss ex Fr) Karst compound on the proliferation and differentiation of K562 leukemic cells. J. Hunan Med. Univ., 24, 521-524.
68. Lieu, C.W.; Lee, S.S. and Wang, S.Y. (1992) The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res., 12, 1211-1215.
69. Wang, S.Y.; Hsu, M.L.; Hsu, H.C.; Tzeng, C.H.; Lee, S.S.; Shiao, M.S. and Ho, C.K. (1997) The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int. J. Cancer, 70, 699-705.
70. Mizushina, Y.; Hanashima, L.; Yamaguchi, T.; Takemura, M.; Sugawara, F.; Saneyoshi, M.; Matsukage, A.; Yoshida, S. and Sakaguchi, K. (1998) A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases. Biochem. Biophys. Res. Commun., 249, 17-22.
71. Mizushina, Y.; Watanabe, I.; Togashi, H.; Hanashima, L.; Takemura, M.; Ohta, K.; Sugawara, F.; Koshino, H.; Esumi, Y.; Uzawa, J.; Matsukage, A.; Yoshida, S. and Sakaguchi, K. (1998) An ergosterol peroxide, a natural product that selectively enhances the inhibitory effect of linoleic acid on DNA polymerase beta. Biol. Pharm. Bull., 21, 444-448.
72. Lee, S.; Park, S.; Oh, J.W. and Yang, C.H. (1998) Natural inhibitors for protein prenyltransferase. Planta Medica, 64, 303-308.
73. Koepf, M.P.; Janiak, C. and Schumann, H. (1988) Antitumor properties of organometallic metallocene complexes of tin and Germanium. J. Cancer Res. Clin. Oncol., 114, 502-506.
74. Mirabelli, C.K.; Badger, A.M.; Sung, C.P.; Hillegass, L.; Sung, C.M.; Johnson, R.K.; Picker, D.; Schwartz, D.; Dorman, J. and Martellucci, S. (1989) Pharmacological activities of spirogermanium and other structurally related azaspiranes effects on tumor cell and macrophage functions. Anticancer Drug Des., 3, 231-242.
75. Lim, U.K. and Choi, K.S. (1991) The study of chemical components of Ganoderma lucidum. J. Agric. Sci., 16: 109-114.
76. Chiu, S.W.; Wang, Z.M.; Leung, T.M. and Moore, D. (2000) Nutritional value of Ganoderma extract and assessment of its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. Food Chem. Toxicol., 38, 173-178.
77. Chen, W.C.; Hau, D.M. and Lee, S.S. (1995) Effects of Ganoderma lucidum and krestin on cellular immunocompetence in gamma-ray-irradiated mice. Am. J. Chin. Med., 23, 71-80.
78. Chen, W.C.; Hau, D.M.; Wang, C.C.; Lin, I.H. and Lee, S.S. (1995) Effects of Ganoderma lucidum and krestin on subset T-cell in spleen of gamma-irradiated mice. Am. J. Chin. Med., 23, 289-298.
79. Lu, Z.W. (1995) Psychoneuroimmunological effects of morphine and the immunoprotection of Ganoderma polysaccharides peptide in morphine-dependent mice. Progress Physiol. Sci., 26, 45-49.
80. Mohammed, A.; Adelaiye, A.B.; Abubakar, M.S. and Abdurahman, E.M. (2007) Effects of aqueous extract of Ganoderma lucidum on blood glucose levels of normoglycemic and alloxaninduced diabetic wistar rats. J. Med. Plants Res., 1(2), 34-37.
81. Hirotani, M.; Ino, C.; Furuya, T. and Shiro, M. (1986) Ganoderic acids T, S and R, new triterpenoids from the cultured mycelia of Ganoderma lucidum. Chem. Pharm. Bull., 34, 2282-2285.
82. Chen, R.Y. and Yu, D.Q. (1993) Studies on the triterpenoid constituents of the spores from Ganoderma lucidum Karst. J. Chin. Pharm. Sci., 2, 91-96.
83. Wang, M.Y.; Liu, Q.; Che, Q.M. and Lin, Z.B. (2002) Effects of total triterpenoids extract from Ganoderma lucidum (Curt.: Fr.) P. Karst. (Reishi Mushroom) on experimental liver injury models induced by carbon tetrachloride or d-galactosamine in mice. Int. J. Med. Mushrooms, 4, 337-342.
84. Joseph, S.; Sabulal, B.; George, V.; Smina, T.P. and Janardhanan, K.K. (2009) Antioxidative and antiinflammatory activities of the chloroform extract of Ganoderma lucidum found in South India. Sci. Pharm., 77, 111-121.
85. Horng-Huey, K.; Chi-Feng, H.; Jih-Pyang, W. and Chun-Nan, L. (2008) Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry, 69(1), 234-239.
86. Lin, J.M.; Lin, C.C.; Chiu, H.F.; Yang, J.J. and Lee, S.G. (1993) Evaluation of the anti-inflammatory and liver-protective effects of Anoectochilus formosanus, Ganoderma lucidum and Gynostermma pentaphyllum in rats. Am. J. Chin. Med., 21, 59-69.
87. Martin, P. (2006) The Use of Ganoderma lucidum. in: the Management of Histamine-Mediated Allergic Responses. In: Townsend Letter for Doctors and Patients, (Collin, J. and Brown L. Ed.), Consolidated Press: Seattle, Washington, pp. 26-30.
88. Calder, P.C. (2003) Immunonutrition. Br. Med. J., 327, p.117.
89. Barrtsch, G.; Rittmaster, R.S. and Klocker, H. (2000) Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia. Eur. Urol., 37, 367-380.
90. Russell, D.W. and Wilson, J.D. (1994) Steroid 5α-reductase: two genes/two enzymes. Annu. Rev. Biochem., 63, 25-61.
91. Jenkins, E.P.; Hsieh, C.L.; Milatovitch, A.; Normington, K.; Berman, D.M.; Francke, U. and Russell, D.W. (1991) Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homolog. Genomics, 11, 1102-1112.
92. Liu, J.; Kuniyoshi, S.; Fumiko, K.; Shoichiro, K. and Ryuichiro, K. (2007) The anti-androgen effect of ganoderol B isolated from the fruiting body of Ganoderma lucidum. Bioorg. Med. Chem., 15, 4966-4972.
93. Fujita, R.; Jie, L.; Kuniyoshi, S.; Fumiko, K.; Kiyoshi, N.; Shoichiro, K.; Chie, U.; Hisatoshi, T.; Shuhei, K.; Yoshitaro, S. and Ryuichiro, K. (2005) Anti-androgenic activities of Ganoderma lucidum. J. Ethnopharmacol., 102, 107-112.
94. Shimizu, K.; Jie, L.; Ichiko, M. and Ryuichiro, K. (2006) The preventative effect of benign prostatic hyperplasia and osteoporosis by Ganoderma lucidum. Foods Food Ingredients J. Jpn., 211, 124-133.
95. Song, Y. S.; Sun-Hyoung, K.; Jae-Hoon, S.; Changbae, J.; Chang-Jin, L. and Eun-Hee, P. (2004) Anti-angiogenic and inhibitory activity on inducible nitric oxide production of the mushroom Ganoderma lucidum. J. Ethnopharmacol., 90, 17-20.
96. Kim, Y.S.; Seong-Kug, E.; Ki-Wan, O.; Chong-kil, L. and Seong-Sun, H. (2000) Antiherpetic activities of acidic protein bound polysaccharide isolated from Ganoderma lucidum alone and in combinations with interferons. J. Ethnopharmacol., 72, 451-458.
97. Eo, S.K.; Young-So, K.; Chong-Kil, L. and Seong-Sun, H. (1999) Antiherpetic activities of various protein bound polysaccharides isolated from Ganoderma lucidum. J. Ethnopharmacol., 68, 175-181.
98. Liu, J.; Yang, F.; Lin-Bai, Y.; Xiao-Jun, Y.; Khalid, A.T.; Yi, Z. and Yu-Hua, W. (2004) Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J. Ethnopharmacol., 95, 265-272.
99. Oh, K.W.; Chong-Kil, L.; Young-So, K.; Seong-Kug, E. and Seong-Sun, H. (2000) Antiherpetic activities of acidic protein bound polysaccharide isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine. J. Ethnopharmacol., 72, 221-227.
100. Karaman, M.A.; Mimica-Dukic, N.M. and Matavulj, M.N. (2005) Lignicolous fungi as potential natural sources of antioxidants. Arch. Biol. Sci., 57(2), 93-100.
101. rd ed., Ten Speed Press: USA.
102. Suay, I.; Arenal, F.; Asensio, F.J.; Basilio, A.; Cabello, M.A.; Diez, M.T.; Garcia, J.B.; del Val, A.G.; Corrochategui, J. Hernandez, P.; Pelaez, F. and Vicente, M.F. (2000) Screening of Basidiomycetes for antimicrobial activities. Antonie Van Leeuwenhoek, 78, 129-139.
103. Yoon, S.Y.; Eo, S.K.; Kim, Y.S.; Lee, C.K. and Han, S.S. (1994) Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch. Pharm. Res., 17, 438-442.
104. Sugiura, M. and Ito, H. (1977) Toxicological studies of Ganoderma lucidum. Tokyo Yakka Daigaku Kenkyu Nenpo, 27, 722-733.
105. Kim, M.J.; Kim, H.W.; Lee, Y.S.; Shim, M.J.; Choi, E.C. and Kim, B.K. (1986) Studies on safety of Ganoderma lucidum. Korean J. Mycol., 14 (1), 49-59.
106. Eo, S.K.; Kim, Y.S.; Lee, C.K. and Han, S.S. (1999) Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J. Ethnopharmacol., 68, 129-136.
107. Eo, S.K.; Kim, Y.S.; Lee, C.K. and Han, S.S. (2000) Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J. Ethnopharmacol., 72, 475-481.
108. Wang, H. and Ng, T.B. (2006) Ganodermin, an antifungal protein from fruiting bodies of the medicinal mushroom Ganoderma lucidum. Peptides, 27, 27-30.
109. Lakshmi, B.; Ajith, T.A.; Jose, N. and Janardhanan, K.K. (2006) Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo (a)pyrene. J. Ethnopharmacol., 107, 297-303.
110. Hong, K.J.; Dunn, D.M.; Shen, C.L. and Pence, B.C. (2004) Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother. Res., 18, 768-770.
111. Jiang, J.; Slivova, V.; Harvey, K.; Valachovicova, T. and Sliva, D. (2004) Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappa B signaling. Nutr. Cancer, 49, 209-216.
112. Hu, H.; Ahn, N.S.; Yang, X.; Lee, Y.S. and Kang, K.S. (2002) Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int. J. Cancer, 102, 250-253.
113. Muller, C.I.; Takashi, K.; James, O.; Navindra, P.; Seeram, D.H. and Koeffler, H.P. (2006) Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk. Res., 30, 841-848.
114. Tang, W.; Jian-Wen, L.; Wei-Ming, Z.; Dong-Zhi,W. and Jian-Jiang, Z. (2006) Ganoderic acid T from Ganoderma lucidum mycelia induces mitochondria mediated apoptosis in lung cancer cells. Life Sci., 80, 205-211.
115. Kabir, Y.; Kimura, S. and Tamura, T. (1988) Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J. Nutr. Sci. Vitaminol., 34, 433-438.
116. Soo, T.S. (1996) Effective Dosage of the Extract of Ganoderma lucidum in the Treatment of Various Ailments, in Mushroom Biology and Mushroom Products, (Royse, Ed.), The Pennsylvania State University: Pennsylvania, US, pp. 177-185.
117. Lee, S.Y. and Rhee, H.M. (1990) Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem. Pharm. Bull., 38, 1359-1364.
118. Jin, H.; Zhang, G.; Cao, X.; Zhang, M.; Long, J.; Luo, B.; Chen, H.; Qian, S.; Mori, M. and Wang, Z. (1996) Treatment of Hypertension by Linzhi Combined with Hypotensor and Its Effects on Arterial, Arteriolar and Capillary Pressure Microcirculation, in Microcirculatory Approach to Asian Traditional Medicine: Strategy for the Scientific Evaluation. Excerpta Medica, International Congress Series Elsevier: Amsterdam, NY, pp. 131-138.
119. Joo, S.S.; Ryu, I.W. and Park, J.K. (2008) Molecular cloning and expression of a laccase from Ganoderma lucidum and its antioxidative properties. Mol. Cells, 25(1), 112-118.
120. Muraleedharan, T. R. and Venkobachar, C. (2004) Mechanism of biosorption of copper (II) by Ganoderma lucidum. Biotech. Bioengg., 35(3), 320-325.
121. (Chang, S.T.; Ed.), (1993) Mushroom Biology and Mushroom Products, The Chinese University Press: Hong Kong, p. 267.
122. Chen, A.W. (1999) Cultivation of the Medicinal Mushroom Ganoderma lucidum (Curtis: Fr.), P. Karst. (Reishi) in North America. Int. J. Med. Mushrooms, 1(3), 263-282.
123. Buchanan, P.K. (2001) A Taxonomic Overview of the Genus Ganoderma with Special Reference to Species of Medicinal and Neutriceutical Importance, (Gao, Y.H.; Zhou, S.F. and Buchanan, P.K. Eds.), Proc. Inter. Symp. Ganoderma Sci., Auckland, pp. 1-7.
124. Moncalvo, J.M. and Ryvarden, L. (1997) A Nomenclatural study of the Ganodermataceae Donk, Synopsis Fungorum 11, Fungiflora: Oslo, Norway, p. 114.
125. Jong, S.C.; Birmingham, J.M. and Pai, S. (1991) Immunomodulatory substances of fungal origin. J. Immunol. Immunopharmacol., 11, 115-122.
126. Hirose, K.; Muto, S.; Niimura, K.; Ohara, M.; Oguchi, Y.; Matsunaga, K.; Kadochi, J.; Sugita, N.; Furushu, T.; Yoshikumi, C. and Takahashi, M. (1988) Antiviral Agent, J.P. Patent No. 63316734.
127. Habijanic J. and Berovic, M. (2000) The relevance of solid-state substrate moisturing on Ganoderma lucidum biomass cultivation. Food Technol. Biotechnol., 38, 225-228.
128. Yang, F.C.; Hsieh, C. and Chen, H.M. (2003) Use of stillage grain from a rice-spirit distillery in the solid state fermentation of Ganoderma lucidum. Process Biochem., 39, 21-26.
129. Hsieh, C. and Yang, F.C. (2004) Reusing soy residue for the solid-state fermentation of Ganoderma lucidum. Bioresour. Technol., 91, 105-109.
130. Veena, S.S. and Meera, P. (2006) Evaluation of the locally available substrate for the cultivation of Indigenous Ganoderma lucidum isolate. J. Mycol. Pl. Pathol., 36(3), 434-438.
131. Peksen, A. and Yakupoglu, G. (2009) Tea waste as a supplement for the cultivation of Ganoderma lucidum. World J. Microbiol. Biotechnol., 25, 611-618.
132. Dubois, M.; Gilles, K.A.; Hamilton, J.K.; Rebers, P. A. and Smith, F. (1956) Colorimetric method for determination of sugars and related substances. Anal. Chem., 28, 350-356.
133. Fang, Q.H. and Zhong, J.J. (2002) Submerged fermentation of higher fungus Ganoderma lucidum for production of valuable bioactive metabolites - ganoderic acid and polysaccharide. Biochem. Eng. J., 10, 61-65.
134. Tang, Y.J. and Zhong, J.J. (2002) Exopolysaccharide biosynthesis and related enzyme activities of the medicinal fungus, Ganoderma lucidum, grown on lactose in a bioreactor. Biotechnol. Lett., 24, 1023-1026.
135. Tang, Y.J. and Zhong, J.J. (2002) Fed-batch fermentation of Ganoderma lucidum for hyperproduction of polysaccharide and ganoderic acid. Enzyme Microb. Technol., 31, 20-28.
136. Wagner, R.; Mitchell, D.A.; Sassaki, G.L.; Maria, A.L.A.A. and Marin B. (2003) Current techniques for the cultivation of Ganoderma lucidum for the production of biomass, ganoderic acid and polysaccharides. Food Technol. Biotechnol., 41(4), 371-382.
137. Yang, F.C. and Liau, C.B. (1998) The influence of environmental condition on polysaccharide formation by Ganoderma lucidum in submerged culture. Proc. Biochem., 33, 547-553.
138. Fang, Q.H. and Zhong, J.J. (2002) Two-stage culture process for improved production of ganoderic acid by liquid fermentation of higher fungus Ganoderma lucidum. Biotechnol. Prog., 18, 51-54.
139. Habijanic, J.; Berovic, M.; Wraber, B.; Hodzar, D. and Boh, B. (2001) Immunomodulatory effects of fungal polysaccharides from Ganoderma lucidum submerged biomass cultivation. Food Technol. Biotechnol., 39, 327-331.
140. Miyahara, H.; Yoshimoto, T. and Asawa, K. (1987) Chemical structures and changes of extracts during growth of Reishi (Ganoderma lucidum). Mokuzai Gakkaishi., 33, 416-422.
141. Yang, F.C. and Liau, C.B. (1998) Effect of cultivation conditions on the mycelial growth of Ganoderma lucidum in submerged flask cultures. Bioprocess Eng., 19, 233-236.
142. Yang, F.C.; Ke, Y.F. and Kuo, S.S. (2000) Effect of fatty acids on the mycelial growth and polysaccharide formation by Ganoderma lucidum in shake flask cultures. Enzyme Microb. Tech., 27, 295-301.
143. Fang, Q.H. and Zhong, J.J. (2002) Effect of initial pH on production of ganoderic acid and polysaccharide by submerged fermentation of Ganoderma lucidum. Process Biochem., 37, 769-774.
144. Fang, Q. H.; Tang, Y.J. and Zhong, J.J. (2002) Significance of inoculation density control in production of polysaccharide and ganoderic acid by submerged culture of Ganoderma lucidum. Process Biochem., 37, 1375-1379.
145. Lee, K.M.; Lee, S.Y. and Lee, H.Y. (1999) Bistage control of pH for improving exopolysaccharide production from mycelia of Ganoderma lucidum in an air-lift fermentor. J. Biosci. Bioeng., 88, 646-650.
146. Tang, Y.J. and Zhong, J.J. (2003) Role of oxygen supply in submerged fermentation of Ganoderma lucidum for production of Ganoderma polysaccharide and ganoderic acid. Enzyme Microb. Technol., 32, 478-484.
147. Kim, S.W.; Hwang, H.J.; Park, J.P.; Cho, Y.J.; Song, C.H. and Yun, J.W. (2002) Mycelial growth and exo-biopolymer production by submerged culture of various edible mushrooms under different media. Lett. Appl. Microbiol., 34, 56-61.
148. Mitchell, D. A. (1992) Biomass determination in solid state cultivation, in Solid Substrate Cultivation, (Doelle, H.W.; Mitchell, D.A. and Rolz, C.E. Eds.), Elsevier Applied Science: London, pp. 53-63.
149. Wang, Y.Y.; Khoo, K.H.; Chen, S.T.; Lin, C.C.; Wong, C.H. and Lin, C.H. (2002) Studies on the immunomodulating and antitumor activities of Ganoderma lucidum (Reishi) polysaccharides: functional and proteomic analyses of a fucose containing glycoprotein fraction responsible for the activities. Bioorg. Med. Chem., 10, 1057-1062.
150. Kim, H.W. and Kim, B.K. (1999) Biomedical triterpenoids of Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae). Int. J. Med. Mushrooms, 1(2), 121-138.
151. Min, B.S.; Gao, J.J.; Nakamura, N. and Hattori, M. (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem. Pharm. Bull., 48, 1026-1033.
152. Chen, J.H.; Zhou, J.P.; Zhang, L.N.; Nakumura, Y. and Norisuye, T. (1998) Chemical structure of the water-insoluble polysaccharide isolated from the fruiting body of Ganoderma lucidum. Poly. J., 30, 838-842.
153. Ooi, V.E.C. and Liu, F. (2000) Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr. Med. Chem., 7, 715-729.
154. Kawagishi, H.; Mitsunaga, S.; Yamawaki, M.; Ido, M.; Shimada, A.; Kinoshita, T.; Murata, T.; Usui, T.; Kimura, A. and Chiba, S. (1997) A lectin from mycelia of the fungus Ganoderma lucidum. Phytochemistry, 44, 7-10.